Skip to main content
Top
Published in: Cancer Cell International 1/2020

Open Access 01-12-2020 | Hepatocellular Carcinoma | Retraction Note

Retraction Note to: Correlations between chromobox homolog 8 and key factors of epithelial–mesenchymal transition in hepatocellular carcinoma

Authors: Xiaonian Zhu, Wei Luo, Chunhua Bei, Juan Kong, Shidong Zhang, Yuanyuan Fu, Di Li, Shengkui Tan

Published in: Cancer Cell International | Issue 1/2020

Login to get access

Excerpt

The Editor-in-Chief has retracted this article [1] because three panels in Figure 2D appear to be the same as three panels in Figure 4A in a previously published article by the same author group [2, retracted]. Specifically:
  • Invasion/shGFP in Figure 2D [1] appears to be the same as Invasion/shGFP in Figure 4A [2]
  • Invasion/shCBX8-1# in Figure 2D [1] appears to be the same as Migration/shGFP in Figure 4A [2]
  • Invasion/shCBX8-3# in Figure 2D [1] appears to be the same as Migration/shMAZ-2# in Figure 4A [2]
Metadata
Title
Retraction Note to: Correlations between chromobox homolog 8 and key factors of epithelial–mesenchymal transition in hepatocellular carcinoma
Authors
Xiaonian Zhu
Wei Luo
Chunhua Bei
Juan Kong
Shidong Zhang
Yuanyuan Fu
Di Li
Shengkui Tan
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2020
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-020-01574-4

Other articles of this Issue 1/2020

Cancer Cell International 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine